Skip to main content
CDLX
NASDAQ Technology

Cardlytics Divests Bridg Platform for Up to $30M in PAR Technology Stock

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Advertising Stocks · Communication
Sentiment info
Neutral
Importance info
9
Price
$1.21
Mkt Cap
$65.408M
52W Low
$0.852
52W High
$4.045
52W Position info
42% above low
Off High info
70% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

CDLX sits 42% above its 52-week low of $0.852 on light trading volume (0.4× avg).

Summary

Cardlytics, Inc. has entered into an agreement to sell its Bridg platform assets to PAR Technology Corporation for up to $30 million in PAR common stock, representing a significant divestiture for the company.


Key Events · M&A and Partnerships · CDLX

  • Asset Purchase Agreement Signed

    Cardlytics, Inc. entered into an agreement on January 23, 2026, to sell its Bridg platform assets to DB Sub, LLC, an indirect subsidiary of PAR Technology Corporation.

  • Significant Transaction Value

    The sale is valued at $27.5 million, with potential adjustments up to $30 million, to be paid in shares of PAR Common Stock. This represents a substantial portion of Cardlytics' market value.

  • Strategic Divestiture

    The transaction involves the sale of all assets primarily related to the Bridg platform, indicating a significant strategic shift or streamlining of operations for Cardlytics.

  • Non-Competition Clause

    The agreement includes customary representations, warranties, and covenants, including a five-year non-competition and non-solicitation clause for Cardlytics regarding the Purchased Assets.


Analysis · CDLX · Technology

This 8-K filing announces a major strategic move for Cardlytics, Inc., involving the sale of its Bridg platform, a substantial asset, to PAR Technology Corporation. The transaction, valued between $27.5 million and $30 million, will be paid entirely in PAR Common Stock. This divestiture represents a significant portion of Cardlytics' current market value, indicating a potential shift in the company's strategic focus or a move to bolster its balance sheet. Investors should monitor the closing of this transaction and the subsequent use of the PAR Common Stock received, as it will significantly impact Cardlytics' future operations and financial structure.

At the time of this filing, CDLX was trading at $1.21 on NASDAQ in the Technology sector, with a market capitalization of approximately $65.4M. The 52-week trading range was $0.85 to $4.05. This filing was assessed with neutral market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CDLX - Latest Insights

CDLX
Jul 06, 2026, 5:52 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $4.37
Real-time Price: $3.90 info
Change: -$0.4737 (-11%) info
Market Cap: $22.629M info
CDLX
Jun 03, 2026, 4:34 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $0.620
Real-time Price: $3.90 info
Change: Reverse Stock Split info
Market Cap: $22.629M info
CDLX
Jun 03, 2026, 4:26 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.6499
Real-time Price: $3.90 info
Change: Reverse Stock Split info
Market Cap: $22.629M info
CDLX
May 20, 2026, 4:04 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.7251
Real-time Price: $3.90 info
Change: Reverse Stock Split info
Market Cap: $22.629M info
CDLX
May 19, 2026, 4:21 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $0.596
Real-time Price: $3.90 info
Change: Reverse Stock Split info
Market Cap: $22.629M info